Use of in Vivo Two-dimensional MR Spectroscopy to Compare the Biochemistry of the Human Brain to That of Glioblastoma
- 1 May 2011
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 259 (2) , 540-549
Abstract
Purpose To develop an in vivo two-dimensional localized correlation spectroscopy technique with which to monitor the biochemistry of the human brain and the pathologic characteristics of diseases in a clinically applicable time, including ascertainment of appropriate postprocessing parameters with which to allow diagnostic and prognostic molecules to be measured, and to investigate how much of the chemical information, known to be available from malignant cultured cells, could be recorded in vivo from human brain. Materials and Methods The study was approved by the institutional review board and was compliant with HIPAA. With use of a 3.0-T clinical magnetic resonance (MR) unit and a 32-channel head coil, localized correlation spectroscopy was performed in six healthy control subjects and six patients with glioblastoma multiforme (GBM) with an acquisition time of 11 minutes. Two-dimensional spectra were processed and analyzed and peak volume ratios were tabulated. The data used were proved to be normally distributed by passing the Shapiro-Wilk normality test. The first row of the spectra was extracted to examine diagnostic features. The pathologic characteristics and grade of each GBM were determined after biopsy or surgery. Statistically significant differences were assessed by using a t test. Results The localized correlation spectroscopy method assigned biochemical species from the healthy human brain. The correlation spectra of GBM were of sufficiently high quality that many of the cross peaks, recorded previously from malignant cell models in vitro, were observed, demonstrating a statistically significant difference (P < .05) between the cross peak volumes measured for healthy subjects and those with GBM (which include lipid, alanine, N-acetylaspartate, γ-aminobutyric acid, glutamine and glutamate, glutathione, aspartate, lysine, threonine, total choline, glycerophosphorylcholine, myo-inositol, imidazole, uridine diphosphate glucose, isocitrate, lactate, and fucose). The first row of the spectra was found to contain diagnostic features. Conclusion Localized correlation spectroscopy of the human brain at 3.0 T with use of a 32-channel head coil was performed in 11 minutes and provided information about neurotransmitters, metabolites, lipids, and macromolecules. The method was able to help differentiate healthy brain from the biochemical signature of GBM in vivo. This method may, in the future, reduce the need for biopsy and is now applicable for the study of selected neurologic diseases. © RSNA, 2011Keywords
This publication has 42 references indexed in Scilit:
- Attenuated AMPA Receptor Expression Allows Glioblastoma Cell Survival in Glutamate-Rich EnvironmentPLOS ONE, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopyInternational Journal of Cancer, 1994
- Localized detection of glioma glycolysis using edited 1H MRSMagnetic Resonance in Medicine, 1993
- Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cellsBiochemistry, 1992
- The effect of altering time domains and window functions in two-dimensional proton COSY spectra of biological specimensJournal of Magnetic Resonance (1969), 1991
- Experimental study of optimal selective 180° radiofrequency pulsesJournal of Magnetic Resonance (1969), 1988
- Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methodsBiochemistry, 1984